Kinaxis Inc. (TSE:KXS – Get Free Report) insider Andrew William Robert Bell sold 703 shares of the firm’s stock in a transaction on Friday, August 14th. The stock was sold at an average price of C$171.46, for a total transaction of C$120,536.38. Following the completion of the sale, the insider owned 1,455 shares of the company’s stock, valued at C$249,474.30. This trade represents a 32.58% decrease in their position.
Kinaxis Stock Performance
TSE KXS opened at C$177.15 on Thursday. The stock has a market capitalization of C$4.82 billion, a price-to-earnings ratio of 57.89, a PEG ratio of 3.60 and a beta of 0.76. The business’s 50 day moving average is C$159.15 and its two-hundred day moving average is C$146.48. Kinaxis Inc. has a 12-month low of C$117.22 and a 12-month high of C$196.63. The company has a current ratio of 1.88, a quick ratio of 2.29 and a debt-to-equity ratio of 11.14.
Kinaxis (TSE:KXS – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. The company had revenue of C$230.64 million during the quarter. Kinaxis had a net margin of 14.40% and a return on equity of 20.88%. Research analysts expect that Kinaxis Inc. will post 4.2526231 EPS for the current year.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Kinaxis
About Kinaxis
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
See Also
- Five stocks we like better than Kinaxis
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
